Omada Health, Inc. — Earnings Quality Grade F
OMDA · Healthcare
Major red flags
Screening Summary
管理层信号
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 19 days, change -1 days YoY
AR growth 43.0% vs revenue growth 53.2%
Revenue 53.2%, CFFO 153.4%. Cash follows revenue
Expense Quality
Inventory 36.1% vs COGS 33.4%. Normal
CapEx growth 51.0% vs revenue 53.2%. Normal
SG&A/Gross Profit = 83.2%, exceeds 70%
Gross margin swung +5.1pp (60.6% → 65.7%)
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
Small-cap context: Small-cap CFFO/NI often diverges from working-capital swings, not necessarily manipulation.
FCF $0.0B, FCF/NI = -0.97
Accruals ratio = -10.2%. Low accruals
Cash $0.2B covers debt $0.0B
Balance Sheet Health
Goodwill+Intangibles $0.0B = 7% of equity. Manageable
Interest coverage = -4.7x (<2x). Financial stress
Other assets -96.7% vs revenue 53.2%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 2/3 years
Goodwill+Intangibles change -11% YoY. Normal
Manipulation Score
M-Score = -2.61 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25